MATERA, Lina
 Distribuzione geografica
Continente #
NA - Nord America 2.703
EU - Europa 2.547
AS - Asia 1.026
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 6.293
Nazione #
US - Stati Uniti d'America 2.637
CN - Cina 727
UA - Ucraina 398
DE - Germania 350
SE - Svezia 315
IE - Irlanda 308
GB - Regno Unito 249
IT - Italia 235
FI - Finlandia 202
FR - Francia 199
KR - Corea 197
PL - Polonia 108
AT - Austria 80
CA - Canada 56
DK - Danimarca 45
VN - Vietnam 38
IN - India 32
GR - Grecia 17
BE - Belgio 11
NL - Olanda 10
MU - Mauritius 9
MX - Messico 9
JP - Giappone 8
RU - Federazione Russa 5
CH - Svizzera 4
SG - Singapore 4
SN - Senegal 4
TR - Turchia 4
HK - Hong Kong 3
SA - Arabia Saudita 3
TW - Taiwan 3
BR - Brasile 2
ES - Italia 2
EU - Europa 2
HU - Ungheria 2
IR - Iran 2
NO - Norvegia 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CR - Costa Rica 1
HR - Croazia 1
IQ - Iraq 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.293
Città #
Beijing 594
Chandler 472
Dublin 307
Jacksonville 202
Ann Arbor 199
Houston 166
Princeton 105
Warsaw 100
Medford 98
Villeurbanne 93
Dearborn 89
Vienna 80
Ashburn 74
Boston 67
Nyköping 67
Torino 58
Milan 57
San Mateo 48
Boardman 47
Fairfield 46
Wilmington 45
Verona 44
Lachine 29
Woodbridge 27
Dong Ket 26
Falls Church 22
Nanjing 21
Toronto 21
Fremont 20
Cambridge 19
Seattle 19
Turin 19
Norwalk 17
Redwood City 12
Brussels 11
Guangzhou 10
Mountain View 10
Nürnberg 10
Sunderland 10
Washington 10
Athens 9
Hefei 9
Jinan 9
Shanghai 9
Hangzhou 8
Kunming 8
Pisa 8
Tappahannock 8
Fuzhou 7
Detroit 6
Hebei 6
New York 6
Shenyang 6
Auburn Hills 5
Chicago 5
Los Angeles 5
Redmond 5
Seoul 5
Bologna 4
Munich 4
Pune 4
Renton 4
Wuhan 4
Zhengzhou 4
Edmonton 3
Geneva 3
Iowa City 3
Nanchang 3
Ottawa 3
Poznan 3
Silver Spring 3
Xian 3
Borgo San Dalmazzo 2
Central 2
Chongqing 2
College Station 2
Cuauhtemoc 2
Düsseldorf 2
Groningen 2
Helsinki 2
Kagoshima 2
Kraków 2
Leiden 2
London 2
Malonno 2
Philadelphia 2
Phoenix 2
Piemonte 2
Saint Petersburg 2
Sala Baganza 2
San Diego 2
San Mauro Torinese 2
Singapore 2
Stavanger 2
São Paulo 2
Taipei 2
Aarhus 1
Allentown 1
Almese 1
Amsterdam 1
Totale 3.595
Nome #
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 360
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. 168
Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells. 161
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer. 136
Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes. 129
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells 128
A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes. 112
Biological and molecular evidence for the production of IL-6 by human natural killer cells in culture. 111
[Tumor samples as a tool for large-scale monitoring of antigen-specific lymphocytes in gastric and colorectal neoplasms] 104
In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma 100
Effect of human interleukin 3 on the susceptibility of fresh leukemia cells to interleukin-2-induced lymphokine activated killing activity. 99
Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors. 92
Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation 89
Obestatin promotes glut-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes 88
Bone marrow stroma-derived prolactin isinvolved in basal and platelet-activating factor-stimulated in vitroerythropoiesis 88
Aliphatic aldehydes inhibit the proliferative response of human peripheral blood lymphocytes to phytohemagglutinin and alloantigens. 87
Communication of the central nervous and the immune systems. 85
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients 83
An approach to simultaneous immunofluorescent and autoradiographic analysis of human normal and neoplastic blood cells. 82
AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin. 82
Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro. 80
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes. 80
Action of pituitary and lymphocyte prolactin. 79
Changes in SRBC binding capacity and T-surface antigen expression on human peripheral blood lymphocytes stimulated by 12-0-tetradecanoilphorbol-13-acetate (TPA). 79
Obestatin promotes GLUT-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes 79
Regulatory action of prolactin on the in vitro growth of CD34+ve humanhemopoietic progenitor cells 78
Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells 77
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients 77
Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. 76
Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells. 75
Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes. 73
Contribution of dendritic cells FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies 73
Endocrine, paracrine and autocrine actions of prolactin on immune cells. 71
Cooperation of pitCooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. 70
Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity 70
Fluoride-containing bioactive glasses inhibit pentose phosphate oxidative pathway and glucose 6-phosphate dehydrogenase activity in human osteoblasts 69
Production of colony-stimulating activity by human natural killer cells: analysis of the conditions that influence the release and detection of colony-stimulating activity. 67
High speed autoradiography on brain tissue sections. 65
Generation of non MHC restricted killing in non-cytotoxic T-lymphocytes from leukaemia patients. 63
Modulation of in vitro myelopoiesis by LGL: different effects on early and late progenitor cells. 63
Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules. 62
Cell surface markers and kinetic features in acute lymphoblastic leukaemia. 61
Cerebrospinal fluid and plasma concentrations of POMC-related peptides in multiple sclerosis 61
Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells. 60
Prolactin in autoimmunity and antitumor defence. 60
DNA synthesis and cell generation pattern of chronic lymphatic leukaemia lymphocytes stimulated by phytohaemagglutinin. 59
In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cells. 58
Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line. 58
Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells. 57
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells 57
Cross-presentation of Tumor Antigens Is Increased by UVC Light Tumor Treatment 56
Low Foxp3 expression in negative sentinel lymph nodes is associated with node metastases in colorectal cancer 56
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. 56
Recognition by monoclonal antibody CB02 of a surface molecule shared by B lymphocytes and a discrete large granular lymphocyte subset with cytotoxic activity. 55
Normal development of lymphokine activated killing (LAK) in peripheral blood lymphocytes from hyperprolactinemic patients. 54
A role for growth hormone and prolactin in leukaemia and lymphoma? 54
Membrane phenotype and functional behaviour of T lymphocytes in hairy cell leukemia (HCL). 53
Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells. 53
Establishment of A Ph1-positive human cell line (BV173). 53
Soluble factor(s) released by Concanavalin A activated lymph node lymphocytes induce proliferation and maturation of chronic lymphocytic leukaemia (CLL) B lymphocytes. 52
Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart 52
Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes. 49
Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. 49
Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities 48
Natural killer activity in hyperprolactinemic patients. 47
Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells. 47
Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes. 47
Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells. 47
Synthesis of a prolactin-like peptide by natural killer cells: positive regulation by CD16 and exogenous prolactin. 46
Non-MHC and MHC-restricted cytotoxic cells in colorectal and gastric cancer patients surgically resected. 45
Increased expression of HSP70 by colon cancer cells is not always associated with access to the dendritic cell cross-presentation pathway 45
Natural killer activity and low-affinity E rosettes in acute leukemias. 44
Up-modulation ofinterferon-gamma mediates the enhancement of spontanous cytotoxicity inprolactin-activated natural killer cells 44
Phenotypic and functional characterization of cell surface structures involved in natural killing 43
The kinetic features of human acute leukaemia as a guide to its chemotherapeutic management. 42
Effect of two aliphatic aldehydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130. 41
Proliferative response of lymphocyte subpopulations differing in avidity for sheep red blood cells after stimulation with normal allogeneic and tumour cells. 41
In vitro evaluation of growth fraction and other kinetic parameters in human acute leukaemia. 41
Immunoregulation by prolactin. An introduction 41
Radioguided surgery in oncological surgery 41
Effect of human alpha-fetoprotein on native and in vitro-stimulated NK activity. 39
Effect of Prolactin on Natural Killer and MHC-restricted Cytotoxic cells 39
Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells. 39
Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia. 39
Generazione in vitro di linfociti con attività citotossica anti-tumorale: il contributo di citochine e ormoni adenoipofisari 35
Modulatory effect of prolactin on the DNA synthesis rate and NK activity of large granular lymphocytes. 35
Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors. 35
Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability. 34
In vitro maturation of dendritic cells from blood progenitors. 34
Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors 32
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. 32
VII Congress of the Italian Neuroimmunology Group. 31
Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. 31
Reduced natural killer T-cells in B-cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu-11, A10, AB8.28. 31
Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia. 30
Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A 28
Lymphokine activated killer (LAK) activity in lymphoproliferative disorders. 27
Re: Markus J. Bader, Ronald Sroka, Christian Gratzke, et al. Laser Therapy for Upper Urinary Tract Transitional Cell Carcinoma: Indications and Management. 26
Normal T-lymphocyte function in patients with Hodgkin's disease in long-lasting remission. 25
Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. 24
Totale 6.529
Categoria #
all - tutte 18.815
article - articoli 0
book - libri 0
conference - conferenze 605
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019160 0 0 0 0 0 0 0 0 0 0 121 39
2019/2020972 37 59 86 50 82 169 131 42 104 95 93 24
2020/2021710 82 30 85 32 85 31 94 7 99 64 32 69
2021/2022826 17 31 38 49 30 27 95 42 30 80 140 247
2022/20231.267 151 91 15 136 128 357 112 60 122 19 40 36
2023/2024329 83 99 26 19 22 40 17 14 0 3 6 0
Totale 6.529